Home Current Issue Previous Issues For Authors Journal Info
Skip Navigation LinksHome > September 2005 - Volume 4 - Issue 3 > The Rate Control, Anticoagulation Therapy, and Electrophysio...
You could be reading the full-text of this article now...
If you have access to this article through your institution, you can view this article in OvidSP.
Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine:
September 2005 - Volume 4 - Issue 3 - pp 121-126
doi: 10.1097/01.hpc.0000174914.89013.4b
Original Article

The Rate Control, Anticoagulation Therapy, and Electrophysiology/Antiarrhythmic Medication Pathway for the Management of Atrial Fibrillation and Atrial Flutter

Herzog, Eyal MD; Fischer, Avi MD; Steinberg, Jonathan S. MD

Supplemental Author Material
Collapse Box

Abstract

Atrial fibrillation is the most common cardiac rhythm disturbance encountered in clinical practice. Recent guidelines for the management of atrial fibrillation are complex and do not include the management of atrial flutter.

To bridge the gap between currently available guidelines and patient management, we have developed a unique, simple, yet comprehensive pathway for the management of atrial fibrillation and atrial flutter. The pathway has been designed with the acronym RACE (rate control, anticoagulation therapy, and electrophysiology/antiarrhythmic medication) to reflect the 3 main components in patient management.

This model is designed to mandate and then markedly improve adherence to the published American College of Cardiology, the American Heart Association and the European Society of Cardiology guidelines.

© 2005 Lippincott Williams & Wilkins, Inc.

Login




Help

Forgot Password?

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.